Terms: = Bone cancer AND FUBP1, FBP, 8880, ENSG00000162613, FUBP AND Prognosis
2 results:
1. [Alternative Splicing Detection as Biomarker Candidates for cancer Diagnosis and Treatment with Establishment of Clinical Biobank in Chiba University].
Matsushita K; Itoga S; Nishimura M; Furuta K; Nomura F
Rinsho Byori; 2015 Mar; 63(3):347-60. PubMed ID: 26524858
[TBL] [Abstract] [Full Text] [Related]
2. Haploinsufficiency of the c-myc transcriptional repressor FIR, as a dominant negative-alternative splicing model, promoted p53-dependent T-cell acute lymphoblastic leukemia progression by activating Notch1.
Matsushita K; Kitamura K; Rahmutulla B; Tanaka N; Ishige T; Satoh M; Hoshino T; Miyagi S; Mori T; Itoga S; Shimada H; Tomonaga T; Kito M; Nakajima-Takagi Y; Kubo S; Nakaseko C; Hatano M; Miki T; Matsuo M; Fukuyo M; Kaneda A; Iwama A; Nomura F
Oncotarget; 2015 Mar; 6(7):5102-17. PubMed ID: 25671302
[TBL] [Abstract] [Full Text] [Related]
